Clopidogrel (Page 7 of 7)

Principal Display Panel

Clopidogrel 75mg tablets #30
(click image for full-size original)
CLOPIDOGREL
clopidogrel tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:66116-494(NDC:0093-7314)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLOPIDOGREL BISULFATE (CLOPIDOGREL) CLOPIDOGREL 75 mg
Inactive Ingredients
Ingredient Name Strength
CROSPOVIDONE
HYDROGENATED COTTONSEED OIL
HYDROXYPROPYL CELLULOSE (TYPE H)
HYPROMELLOSE 2910 (15 MPA.S)
FD&C BLUE NO. 2
COCHINEAL
ALUMINUM OXIDE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
LACTOSE
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
POLYETHYLENE GLYCOL 4000
SODIUM LAURYL SULFATE
TITANIUM DIOXIDE
Product Characteristics
Color PINK (light pink to pink) Score no score
Shape OVAL (capsule shaped) Size 13mm
Flavor Imprint Code TV;7314
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:66116-494-30 30 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA076999 05/17/2012
Labeler — MedVantx, Inc. (806427725)
Registrant — Teva Pharmaceuticals USA Inc (118234421)
Establishment
Name Address ID/FEI Operations
Blenheim Pharmacal, Inc. 171434587 REPACK (66116-494)

Revised: 05/2012 MedVantx, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.